These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23211342)

  • 1. Implementation and first results of a German chronic kidney disease registry.
    Kleophas W; Bieber B; Robinson BM; Duttlinger J; Fliser D; Lonnemann G; Rump LC; Pisoni RL; Port FK; Reichel H;
    Clin Nephrol; 2013 Mar; 79(3):184-91. PubMed ID: 23211342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
    Mariani L; Stengel B; Combe C; Massy ZA; Reichel H; Fliser D; Pecoits-Filho R; Lopes AA; Yamagata K; Wada T; Wong MM; Speyer E; Port FK; Pisoni RL; Robinson BM
    Am J Kidney Dis; 2016 Sep; 68(3):402-13. PubMed ID: 27113505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study.
    Thilly N; Boini S; Kessler M; Briançon S; Frimat L
    J Eval Clin Pract; 2009 Feb; 15(1):121-8. PubMed ID: 19239592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
    Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
    Verdalles U; García de Vinuesa S; Goicoechea M; Gómez Campderá F; Luño J
    Nefrologia; 2007; 27(3):320-8. PubMed ID: 17725451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
    Kumar N; Lindberg J; David K; Morris J; Menoyo J
    Am J Nephrol; 2009; 29(2):71-8. PubMed ID: 18689981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification.
    Owens CD; Ho KJ; Kim S; Schanzer A; Lin J; Matros E; Belkin M; Conte MS
    J Vasc Surg; 2007 May; 45(5):944-52. PubMed ID: 17391900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program.
    Schwedt E; Solá L; Ríos PG; Mazzuchi N;
    Nephron Clin Pract; 2010; 114(1):c47-59. PubMed ID: 19816043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale).
    Thilly N; Boini S; Kessler M; Briançon S; Frimat L
    Nephrol Dial Transplant; 2009 Mar; 24(3):934-9. PubMed ID: 19001561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of renal insufficiency in the diabetes TUV of the Deutsche BKK].
    Wolf G; Müller N; Tschauner T; Müller UA
    Med Klin (Munich); 2006 Jun; 101(6):441-7. PubMed ID: 16767567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.
    Curtis BM; Barrett BJ; Djurdjev O; Singer J; Levin A
    Am J Kidney Dis; 2007 Nov; 50(5):733-42. PubMed ID: 17954286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt.
    Gouda Z; Mashaal G; Bello AK; El Attar A; El Kemmry T; El Reweny A; El Nahas M
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1055-63. PubMed ID: 21912051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre.
    Wolf G; Busch M; Müller N; Müller UA
    Nephrol Dial Transplant; 2011 Dec; 26(12):4017-23. PubMed ID: 21493815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration.
    Hommel K; Rasmussen S; Madsen M; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):947-51. PubMed ID: 19861312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD.
    Jones C; Roderick P; Harris S; Rogerson M
    Am J Kidney Dis; 2006 Jan; 47(1):103-14. PubMed ID: 16377391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anemia in predialysis chronic kidney disease patients.
    Shaheen FA; Souqiyyeh MZ; Al-Attar BA; Karkar A; Al Jazairi AM; Badawi LS; Ballut OM; Hakami AH; Naguib M; Al-Homrany MA; Barhamein MY; Ahmed AM; Khardaji MM; Said SA;
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):456-63. PubMed ID: 21566300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.